chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 at 12:45 (at the age of 50-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient had no allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 13:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for unknown indication since an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 01:00, the patient experienced 18-hour fever (101.00 degrees), headache and muscle aches. Lab data on 27Mar2021 included body temperature (reported as fever 101.00 degree) and result was 101.00 degree at 01:00. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken for the adverse events. The clinical outcome of the event fever was recovered on 27Mar2021 at 19:00, while that of the events headache and muscle ache were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt rec'd Imovax Rabies on 16AUG90 developed headache, achy all over (like a bad case of "flu") after 1st dose of vaccine & RIG. 2nd dose 18AUG90, woke up 19AUG90w/ swollen face, puffy around eyes & diarrhea. Feels weak & tired in afternoon.
After receiving the vaccine, while sitting In the recovery area, the client passed out for couple of seconds. Mother of child stated that the child has a history of passing out after vaccines. Prior to , the client passing out, the client witnessed his sister vomit. RN  was present at time of incident and client was sitting on floor with his mother after fainting. Client's pulse taken and was regular.  Client seen by medical director- Dr.. Client began drinking juice no further treatment or issues noted.
Redness and swelling at injection site L thigh. Keflex 125 mg tid x 10 days
pt recvd MMR vax on 4JUN91 & on the same day was exposed to pt who had measles; 13JUN91 devel swollen glands, sore throat, runny nose & bright, red rash on face, neck, chest & arms; had no fever; felt that had contracted measles; pt recove;
Felt a bit of sore arm; Headache; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Felt a bit of sore arm) and HEADACHE (Headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A217) for COVID-19 vaccination.     The patient's past medical history included HbA1C increased (a couple months ago, it was because of inactive insulin she was taking). Previously administered products included for Product used for unknown indication: flu vaccine (3 weeks ago). Past adverse reactions to the above products included No adverse event with flu vaccine. Concurrent medical conditions included Allergic reaction to analgesics (allergic to Paracetamol and Acetaminophen), Hypothyroidism (8 or 9 years ago) and Type 1 diabetes mellitus (8 or 9 years ago). Concomitant products included LEVOTHYROXINE for Hypothyroidism, INSULIN GLULISINE (APIDRA SOLOSTAR) and INSULIN DEGLUDEC (TRESIBA) for Type 1 diabetes mellitus, VITAMIN D NOS and IRON for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Felt a bit of sore arm) and HEADACHE (Headache). On 18-Mar-2021, PAIN IN EXTREMITY (Felt a bit of sore arm) and HEADACHE (Headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The year of birth of the patient was reported.  Patient did not receive any treatment.   This case was linked to MOD-2022-679416, MOD-2022-679419 (Patient Link).   Reporter did not allow further contact
Sudden onset of vertigo, which was really bad for 15 plus days and intermittent for 20 additional days. The doctor said it was an unknown call of vertigo.
arm still has a little swelling and soreness; red before but not today; arm still has a little swelling and soreness; red before but not today; arm still has a little swelling and soreness; red before but not today; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (arm still has a little swelling and soreness; red before but not today), PAIN IN EXTREMITY (arm still has a little swelling and soreness; red before but not today) and ERYTHEMA (arm still has a little swelling and soreness; red before but not today) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced SWELLING (arm still has a little swelling and soreness; red before but not today), PAIN IN EXTREMITY (arm still has a little swelling and soreness; red before but not today) and ERYTHEMA (arm still has a little swelling and soreness; red before but not today). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, SWELLING (arm still has a little swelling and soreness; red before but not today), PAIN IN EXTREMITY (arm still has a little swelling and soreness; red before but not today) and ERYTHEMA (arm still has a little swelling and soreness; red before but not today) outcome was unknown. Not Provided          No concomitant medications were reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   This case was linked to MOD-2021-076541 (Linked Report).; Sender's Comments:  MOD-2021-076541:First dose case
HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included migraine. The patient was previously treated with acetylsalicylic acid/caffeine/paracetamol/salicylamide for migraine.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
pain, nausea, temp went home from work & went to bed;took APAP;
Patient has a body rash and complains of cough from the day of administration - pt only came by after 5 days and complained of it. I called Dr and they are to follow up with patient.
pulled the syringe to early that the complete dose could not be injected in the patient body; it spilled off from the needle and on the patient's arm; A spontaneous report was received from a Healthcare Professional, concerning a patient of unknown age, who was administered Moderna's COVID-19 vaccine and the reporter noticed that one of their nurse pulled the syringe to early that the complete dose could not be injected in the patient body and it spilled off from the needle and on the patient's arm/ underdose.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, the patient received their second dose of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly in an unknown arm for prophylaxis of COVID-19 infection.   The reporter noticed that one of their nurse while administering the vaccine to a patient that she pulled the syringe to early that the complete dose could not be injected in the patient body and it spilled off from the needle and on the patient's arm on an unknown date.  The patient received both scheduled doses of mRNA-1273 therefore, action taken with the drug in response to the event was not applicable.  The outcome of event, pulled the syringe to early that the complete dose could not be injected in the patient body and it spilled off from the needle and on the patient's arm was considered as resolved.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273, lot # 041L20A with no associated AEs.
Flu shot... i was a pilot and scuba diver.... at grocery store.. felt like movie scene where the hall way goes stretching out.. i didn't pass out.. i fought it... talking breathing walking.. could find front of store.. i could see but didn't recognize anything... just kept talking loud trying to get someones attention...i went on for about  45 minutes i fought it till ambulance came... i refused to let myself pass out.
tested positive from covid-19 virus; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine, solution for injection) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date it was reported that she got her 1st dose and about a week later she tested positive from covid-19 virus. She was done with the quarantine and already surpassed the covid-19 virus. she had to start over or wait for weeks or months to take her 2nd dose of vaccine. The outcome of the event was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
MOP states that daughter woke up morning following her vaccinations with nickel size hives on her calves, elbows. MOP states that she put on a topical anti-itch steroidal cream and the hives went away. Patient did not seen bothered by the hives and had no other symptoms with her reaction. MOP states that the next morning, day 2 following vaccines, daughter woke up with nickel size hives again but on her back. MOP applied the same topical anti-itch steroidal cream and the hives went away. MOP reports no other symptoms.
Product supply issue; This case was reported by a other health professional via call center representative and described the occurrence of product supply issue in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product supply issue. On an unknown date, the outcome of the product supply issue was unknown.  Additional details were received as follows: The age at vaccination was not applicable for this report. The age group was not provided, but was selected adult as per the vaccine indication. The health care professional (HCP) called to report regarding the group of patients of unknown age and gender that have not received their second Shingrix vaccine due to vaccine supply issue. HCP did not have the exact number of patients or which patients they were at the time of call. The reporter consented to follow up. The VAERS details were reported for 1st dose.
COLD SWEATS; BODY ACHE; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number has not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced cold sweats, body ache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, cold sweats, and body ache. This report was non-serious.
After administering the vaccine, a small amount of bleeding noted at injection site. Cleaned with gauze, no further bleeding noted. Immediately noticed a small dimed sized firm nodule formed under skin. Patient denied pain and no other symptoms. Observed in the monitoring area for 30 minutes and the nodule started to decrease in size.
This spontaneous report was received from a healthcare worker referring to an unspecified patients of unknown age and gender. On an unknown dates, the patients were orally vaccinated with improperly stored doses of oral, ROTATEQ (dose, frequency were not reported), lot # reported as L027070 with expiration date: 30-APR-2017, lot # reported as L029615 with expiration date: 15-MAY-2017). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Lips began to swell and tongue swelled, swallowing felt "funny". No visible swelling of tongue but pt said felt swollen. Slight swelling of upper and lower lips.
Meibomian gland dysfunction everted lid, conjunctivochalasis indeterminate chemosis 2+ both eyes
Was given 2nd dose of Moderna Vaccine 20 days after 1st dose.No apparent injury, patient was monitored for 30 min in the COVID vaccine clinic in the gym no adverse reactions noted
*Please note it is not known if event was related to vaccine*  On 2/10/2021, at approximately 5:30 AM, patient began to experience dizziness and shortness of breath. Per witnesses, he then began to have seizure activity followed by cardiac arrest. He was treated with CPR and 1 shock from the AED, which resulted in spontaneous return of circulation. He was awake and confused after return of pulse and sent to Hospital Emergency Room.  This event occurred 19 days post first vaccine.  He was scheduled to get his second dose on 2/12/2021, but did not receive it due to event.
No symptoms or additional adverse effects reported; an unspecified dose in VARIVAX immnunization series was administered to patient after being improperly stored.; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's pertinent medical history, historical drug, concurrent conditions and previous drug reactions or allergies were not reported.      On 12-JUN-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot number S031496, which was verified to be a valid one, and expiration date reported and validated as 07-OCT-2021 (dose number, dosage schedule, anatomical site of injection and route of administration were not provided), as prophylaxis (product storage error). The administered vaccine was reconstitued with a properly stored sterile diluent (DILUENT MRK) (lot number S033782, which has been verified to be valid, and expiration date  not reported but upon internal validation established as 18-JUN-2022). The vaccine was exposed to a temperature of 40.1 degrees Fahrenheit (F) during a time frame of 4 hours. There was a previous temperature excursion of 5.7 degrees Celcius (C) for a time frame of 8 hours, as recorded by digital data logger. No symptoms or additional adverse effects reported.
This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative. A 18 year old female patient of an unspecified race and ethnicity received, on 31May2017, the first dose of TRUMENBA in the arm, at single dose, for immunization. Relevant medical history included Crohn's disease. Concomitant medications were unknown. On 31May2017, the patient experienced swelling of feet, joint pain in knees and feet and fever. Clinical outcome of the events was unknown at time of this report.
Felt dizzy and had tingling of lips about 4 min after vaccine.  VSS.  Laid on cot for ~20 min.  Left on own without assistance.  Symptoms resolved.
This spontaneous report has been received from a nurse via field representative referring to a 12 month-old patient of unknown gender. The patient's medical history and current condition was not reported. The patient experienced an unspecified adverse reaction after administration of VARIVAX and MMR II on unspecified date. No detail information was provided about the vaccination. The outcome of the adverse event was unknown. The causality as reported was unknown. Additional information has been requested.
Patient requested the first dose of the Moderna COVID-19 vaccination. Received vaccination even though patient is 17 years old (under the recommended age for Moderna).
her sister's left foot had swelled after getting the vaccine; This is a spontaneous report received from a contactable consumer. This consumer reported for a female patient (owner's sister). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number and expiry dates were not provided) via an unspecified route of administration on an unspecified date, at unknown dose single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. When the reporter was at a consignment store and was talking to the owner about the vaccine her sisters left foot had swelled after getting the vaccine (unknown date). The outcome of the event was unknown.  Information on the lot/batch number has been requested.
took the band aid off ant it was red exact length and width of the band aid; took the band aid off ant it was / swollen exact length and width of the band aid; took the band aid off ant it was / hot exact length and width of the band aid; This case was reported by a consumer via interactive and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2020, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The next day, the patient took the band aid off and it was red and swollen and hot the exact length and width of the band aid.
The needle separated from the syringe and the patient was given half of the dose.; Given half of the dose; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: NEEDLE ISSUE (non-serious), outcome "unknown", described as "the needle separated from the syringe and the patient was given half of the dose."; UNDERDOSE (non-serious), outcome "unknown", described as "Given half of the dose".  Additional information: One of his nurses was giving a patient the vaccine. however, in the process the needle separated from the syringe and the patient was given half of the dose. Doctor was wondering if that patient needed to be revaccinated.  .No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Developed Bronchitis 3 months after 2nd booster. Saw PCP. Prescribed a Z-PAK. Recovered 2 weeks later.
fever, sweats, body aches, headache, watery eyes fever sweats started at 3:30 am. Body aches 5:00am along with headache and constant watery eyes. Difficulty taking deep breaths due to muscle soreness in back and ribs
Weakness; I got like I had flu and cold, chills whatever you talk chill problem; I got like I had flu and cold, chills whatever you talk chill problem; I got like I had flu and cold, chills whatever you talk chill problem; Tired; Sleepy; I had both Covid vaccination dosage and I had Covid infection; I took this bad things and I was ill; I had both Covid vaccination dosage and I had Covid infection; I took this bad things and I was ill; This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration on 07Apr2021 (Lot Number: EN6207) as dose 2, single and dose 1 via an unspecified route of administration on 15Mar2021 (Lot Number: EN6201) as dose 1, single for COVID-19 immunization (at the age of 60-year-old). The patient medical history and concomitant medications were not reported. The patient reported that he had both COVID vaccination dosage and had COVID infection; he took this bad things and he was ill (medically significant) and developed weakness, got like he had flu and cold, chills whatever you talk chill problem, tired and sleepy. On an unspecified date, the patient underwent lab tests and procedures which included COVID-19 test: unknown. The patient was treated with unspecified medication as a therapeutic measure of had both COVID vaccination dosage and had COVID infection; he took this bad things and he was ill. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
pt recvd vax & exp mild sz;EMS called, sz had ceased by the time EMS arrived;t104.4R;APAP given;t102 p/APAP
Apprehension;  Numbness and tingling.  3:15PM B/P 102/74 97 16;     3:20PM  B/P 105/70  90  16. DISPOSITION:  Stable, declined medication or EMS.
Patient is an 83-year-old female, who presents to hospital with progressive generalized lethargy and shortness of breath.  The patient was diagnosed with coronavirus by PCR in the emergency room.  Chest x-ray was obtained, which revealed scattered bilateral lung infiltrates.  The patient reports mild intermittent cough, progressive generalized lethargy.  She has remained afebrile through the course of hospitalization and hemodynamically stable.  Her room air oxygen saturation was 88%.  She is currently 91% on 2 L of oxygen.  Tested positive on 8/24/2021
Admitted to hospital on 1/27/22 for medication induction of labor, found COVID+ test upon admission (reported possible COVID exposure over 2 weeks ago but not tested at that time), asymptomatic. pt is currently in delivery room, have not delivered yet
I started having dry throat and I started itching and getting red all over. I received water and they sent me home within an hr and later on that night I had a really bad headache for three days.
MMR shot Tues. 5/2. Wed. t/10 thru Mon May 15, pt had fever, mild sore throat, swollen glands on side of neck, fatigue, decreased appetite. In addition to above symptoms on Mon. May 15, he complained of headache. Tues. May 16, starting to feel better. Back to school on Wed. May 17. Treated with Tylenol and Motrin, alternating q 4-6 hrs for 2 1/2 days.
Headache, Arthralgia, Fever, kidney pain, neck pain, diaphoresis, brain fog, extreme fatigue Narrative: